imiquimod has been researched along with Hypomelanosis in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Edgar, N; Hogan, DJ; Pilkington, S | 1 |
Akasaka, T; Mori, S | 1 |
Long, FQ; Qian, YH; Zhao, LS | 1 |
Godbolt, A; Sriprakash, K | 1 |
Ahn, JH; Hwang, HS; Kang, HY; Kang, SU; Kim, CH; Lee, MH; Pyun, JH | 1 |
Burnett, CT; Kouba, DJ | 1 |
Brown, T; Cotsarelis, G; Gelfand, JM; Zirvi, M | 1 |
Mendonça, CO; Yates, VM | 1 |
Blyumin, M; Jacob, SE | 1 |
2 review(s) available for imiquimod and Hypomelanosis
Article | Year |
---|---|
Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Biopsy, Needle; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Hypopigmentation; Imiquimod; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Risk Assessment; Skin Neoplasms; Vitiligo | 2009 |
Imiquimod-induced depigmentation: report of two cases and review of the literature.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Hypopigmentation; Imiquimod; Male; Middle Aged; Skin Neoplasms; Vitiligo | 2012 |
7 other study(ies) available for imiquimod and Hypomelanosis
Article | Year |
---|---|
Imiquimod-induced hypopigmentation following treatment of periungual verruca vulgaris.
Topics: Adjuvants, Immunologic; Aminoquinolines; Humans; Hypopigmentation; Imiquimod; Male; Middle Aged; Paronychia; Skin Diseases, Viral; Warts | 2018 |
Imiquimod-induced vitiligo-like hypopigmentation after treatment for radiation keratosis.
Topics: Adjuvants, Immunologic; Aminoquinolines; Dermatologic Agents; Humans; Hypopigmentation; Imiquimod; Keratosis; Male; Middle Aged; Radiation Injuries | 2016 |
Vitiligo or Vitiligo-like Hypopigmentation Associated with Imiquimod Treatment of Condyloma Acuminatum: Not a Casual Event.
Topics: Adult; Aminoquinolines; Condylomata Acuminata; Female; Humans; Hypopigmentation; Imiquimod; Male; Middle Aged; Vitiligo | 2017 |
Imiquimod induces apoptosis of human melanocytes.
Topics: Adjuvants, Immunologic; Aminoquinolines; Apoptosis; Caspase 3; Cells, Cultured; Humans; Hypopigmentation; Imiquimod; In Situ Nick-End Labeling; Melanocytes; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Vitiligo | 2010 |
Vitiligo-like hypopigmentation associated with imiquimod treatment of genital warts.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Condylomata Acuminata; Genital Diseases, Male; Humans; Hypopigmentation; Imiquimod; Male | 2005 |
Permanent facial hypopigmentation following treatment with imiquimod cream.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Humans; Hypopigmentation; Imiquimod; Male; Steroids; Treatment Outcome | 2006 |
Vitiligo-like hypopigmentation with poliosis following treatment of superficial basal cell carcinoma with imiquimod.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Hypopigmentation; Imiquimod; Male; Skin Neoplasms; Thorax | 2008 |